39 related articles for article (PubMed ID: 1296008)
1. Pharmacoeconomic burden of undertreating hypertension.
Degli Esposti L; Valpiani G
Pharmacoeconomics; 2004; 22(14):907-28. PubMed ID: 15362928
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoeconomics of hypertension management: the place of combination therapy.
Ambrosioni E
Pharmacoeconomics; 2001; 19(4):337-47. PubMed ID: 11383751
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic considerations in the management of hypertension.
Pardell H; Tresserras R; Armario P; Hernández del Rey R
Drugs; 2000; 59 Suppl 2():13-20; discussion 39-40. PubMed ID: 10678593
[TBL] [Abstract][Full Text] [Related]
4. Noncompliance with antihypertensive therapy. Economic consequences.
Skaer TL; Sclar DA; Robison LM
Pharmacoeconomics; 1996 Jan; 9(1):1-4. PubMed ID: 10160083
[No Abstract] [Full Text] [Related]
5. [Pathogenesis and epidemiology of arterial hypertension].
Pardell H; Armario P; Hernández R
Drugs; 1998; 56 Suppl 2():1-10. PubMed ID: 9813737
[TBL] [Abstract][Full Text] [Related]
6. The growth of medical science: the lessons of Malthus.
Swales JD
J R Coll Physicians Lond; 1995; 29(6):490-501. PubMed ID: 8748106
[No Abstract] [Full Text] [Related]
7. Economics of hypertension control. World Hypertension League.
Bull World Health Organ; 1995; 73(4):417-24. PubMed ID: 7554012
[TBL] [Abstract][Full Text] [Related]
8. Cost of hypertension treatment and the price of health.
Menard J; Cornu P; Day M
J Hum Hypertens; 1992 Dec; 6(6):447-58. PubMed ID: 1296008
[No Abstract] [Full Text] [Related]
9. Cost effective analyses in the treatment of high blood pressure.
Fletcher A
J Hum Hypertens; 1992 Dec; 6(6):437-45. PubMed ID: 1296007
[No Abstract] [Full Text] [Related]
10. [A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension].
Willenheimer R; Nyström F; Berggren B; Lindström T; Cizinsky S; Weiss L
Lakartidningen; 2008 Oct 22-28; 105(43):3055-6. PubMed ID: 19024623
[No Abstract] [Full Text] [Related]
11. Relative costs of antihypertensive drug treatment.
Strasser T
J Hum Hypertens; 1992 Dec; 6(6):489-94. PubMed ID: 1296015
[No Abstract] [Full Text] [Related]
12. Angiotensin receptor blockers: impact on costs of care.
Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
[TBL] [Abstract][Full Text] [Related]
13. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies].
Rorive G; Delporte JP
Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
